Transient ischaemic attack: Clinical relevance, risk prediction and urgency of secondary prevention

Current Opinion in Neurology

Volumn 22, Issue 1, 2009, Pages 46-53

  Giles, Matthew F ^a,b   Rothwell, Peter M ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

ABCD; Prediction; Risk; Stroke; Transient ischaemic attack

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; ENDARTERECTOMY; HIGH RISK PATIENT; HUMAN; INCIDENCE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PROGNOSIS; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; SECONDARY PREVENTION; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGE FACTORS; HUMANS; ISCHEMIC ATTACK, TRANSIENT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SECONDARY PREVENTION; STROKE;

EID: 60449118380     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32831f1977     Document Type: Review

References (59)

1. Rothwell PM. Incidence, risk factors and prognosis of stroke and transient ischaemic attack: the need for high-quality large-scale epidemiological studies. Cerebrovasc Dis 2003; 16 (Suppl 3):2-10.
2. Department of Health. National Stroke Strategy. UK Department of Health. 2007. UK guidelines for management of TIA.
3. Sacco RL, Adams R, Albers G, et al. American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/ American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37:577-617.
4. Dennis MS, Bamford JM, Sandercock PA, Warlow CP. Incidence of transient ischemic attacks in Oxfordshire, England. Stroke 1989; 20:333-339.
5. Rothwell PM, Coull AJ, Giles MF, et al., Oxford Vascular Study. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004; 363:1925-1933.
6. Giles MF, Rothwell PM. Substantial underestimation of the need for outpatient services for TIA and minor stroke. Age Ageing 2007; 36:676-680. Recent data on TIA incidence according to stringent and pragmatic definitions in population-based study (Oxford Vascular Study), reporting a high rate of 'pragmatically defined' TIA and corresponding demand for specialist TIA (outpatient) services.
7. Kleindorfer D, Panagos P, Pancioli A, et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke 2005; 36:720-723.
8. Brown RD Jr, Petty GW, O'Fallon WM, et al. Incidence of transient ischemic attack in Rochester, Minnesota, 1985-1989. Stroke 1998; 29:2109-2113.
9. Johnston SC. Clinical practice. Transient ischemie attack. N Engl J Med 2002; 347:1687-1692.
10. Rothwell PM, Coull AJ, Silver LE, et al., Oxford Vascular Study. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005; 366:1773-1783.
11. Jungehulsing GJ, Muller-Nordhorn J, Nolle CH, et al Prevalence of stroke and stroke symptoms: a population-based survey of 28,090 participants. Neuroepidemiology 2008; 30:51-57. Recent study of prevalence of stroke and TIA symptoms in an urban population showing high rates of symptoms that are not reported to medical attention.
12. Johnston SC, Fayad PB, Gorelick PB, et al. Prevalence and knowledge of transient ischemic attack among US adults. Neurology 2003; 60:1429-1434.
13. Hodgson C, Lindsay P, Rubini F. Can mass media influence emergency department visits for stroke? Stroke 2007; 38:2115-2122.
14. Reeves MJ, Rafferty AP, Aranha AA, Theisen V. Changes in knowledge of stroke risk factors and warning signs among Michigan adults. Cerebrovasc Dis 2008; 25:385-391.
15. Rothwell PM, Warlow CP. Timing of transient ischaemic attacks preceding ischaemic stroke. Neurology 2005; 64:817-820.
16. Hankey GJ, Slattery JM, Warlow CP. The prognosis of hospital-referred tran-sient ischaemic attacks. J Neurol Neurosurg Psychiatry 1991; 54:793-802.
17. Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991; 54:1044-1054.
18. The Dutch TIA Study Group. The Dutch TIA trial: protective effects of low dose aspirin and atenolol in patients with transient ischemic attacks or nondisabling stroke. Stroke 1988; 19:512-517.
19. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000; 284:2901-2906.
20. Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2007; 6:1063-1072. Meta analysis of studies of early risk of stroke following TIA. All studies reporting the risk of stroke at 2 and 7 days after TIA were identified using multiple methods of electronic and hand searching. Rate of stroke following TIA at 7 days was 5.2% among 10126 patients. Significant heterogeneity between studies was best explained by study setting and method.
21. Wu CM, McLaughlin K, Lorenzetti DL, et al. Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med 2007; 167:2417-2422. Meta-analysis of studies of early risk of stroke following TIA studying outcomes at 2, 30 and 90 days.
22. Johnston SC, Nguyen-Huynh MN, Schwarz ME, et al. National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol 2006; 60:301-313.
23. Albucher JF, Martel P, Mas JL. Clinical practice guidelines: diagnosis and immediate management of transient ischemic attacks in adults. Cerebrovasc Dis 2005; 20:220-225.
24. Nguyen-Huynh MN, Johnston SC. Is hospitalization after TIA cost-effective on the basis of treatment with tPA? Neurology 2005; 65:1799-1801.
25. Hankey GJ, Slattery JM, Warlow CP. Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events? J Neurol Neurosurg Psychiatry 1992; 55:640-652.
26. Yernan WN, Viscoli CM, Brass LM, et al. The stroke prognosis instrument II (SPI-II): a clinical prediction instrument for patients with transient ischemia and nondisabling ischemie stroke. Stroke 2000; 31:456-462.
27. Hill MD, Yiannakoulias N, Jeerakathil T, et al. The high risk of stroke immediately after transient ischemic attack. A population-based study. Neurology 2004; 62:2015-2020.
28. Gladstone DJ, Kapral MK, Fang J, et al. Management and outcomes of transient ischaemic attacks in Ontario. CMAJ 2004; 1707:1099-1104.
29. Rothwell PM, Giles MF, Flossman E, et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 2005; 366:29-36.
30. Bamford J, Sandercock P, Dennis M, et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. I: methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry 1988; 51:1373-1380.
31. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007; 369:283-292. Refinement and revalidation of ABCD system and ABCD2 score. Further validation of ABCD system in cohorts of patients ascertained in ED, population-based and clinic-based cohorts in California, USA and Oxfordshire, UK.
32. Giles MF, Rothwell PM. Systematic review and meta-analysis of validations of the ABCD and ABCD2 scores in prediction of stroke risk after transient ischaemic attack. Cereborvasc Dis 2008; 25 (Suppl 2):59. Meta-analysis and systematic review of validation studies of ABCD system. All validation cohorts were identified using multiple methods of electronic and hand searching. Validity of ABCD system was tested using AUC statistics according to study setting and for independent investigators.
33. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004; 62:569-573.
34. Donnan GA, O'Malley HM, Quang L, et al. The capsular warning syndrome: pathogenesis and clinical features. Neurology 1993; 43:957-962.
35. Fairhead JF, Mehta Z, Rothwell PM. Population-based study of delays in carotid imaging and surgery and the risk of recurrent stroke. Neurology 2005; 65:371-375.
36. van Swieten JC, Kappelle LJ, Algra A, et al., for the Dutch TIA Study Group. Hypodensity of cerebral white matter in patients with transient ischaemic attack or minor stroke: influence on the rate of subsequent stroke. Ann Neurol 1992; 32:177-183.
37. Sciolla R, Melis F, SINPAC Group. Rapid identification of high-risk transient ischemic attacks: prospective validation of the ABCD score. Stroke 2008; 39:297-302. Validation of ABCD system and refinement with the addition of brain imaging.
38. Douglas VC, Johnston CM, Elkins J, et al. Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke 2003; 34:2894-2898.
39. Schulz UG, Briley D, Meagher T, et al. Diffusion-weighted MRI in 300 patients presenting late with subacute transient ischemic attack or minor stroke. Stroke 2004; 35:2459-2465.
40. Oppenheim C, Lamy C, Touzé E, et al. Do transient ischemic attacks with diffusion-weighted imaging abnormalities correspond to brain infarctions? AJNR Am J Neuroradiol 2006; 27:1782-1787.
41. Purroy F, Montaner J, Rovira A, et al. Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions. Stroke 2004; 35:2313-2319.
42. Courts SB, Simon JE, Eliasziw M, et al. Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol 2005; 57:848-854.
43. Wen HM, Lam WW, Rainer T, et al. Multiple acute cerebral infarcts on diffusion-weighted imaging and risk of recurrent stroke. Neurology 2004; 63:1317-1319.
44. Sylaja PN, Coutts SB, Subramaniam S, et al. Acute ischemic lesions of varying ages predict risk of ischemic events in stroke/TIA patients. Neurology 2007; 68:415-419.
45. Crisostomo RA, Garcia MM, Tong DC. Detection of diffusion-weighted MRI abnormalities in patients with transient ischemic attack: correlation with clinical characteristics. Stroke 2003; 34:932-937.
46. Redgrave JN, Coutts SB, Schulz UG, et al. Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack. Stroke 2007; 38:1482-1488. Systematic review of associations between DWI abnormalities and clinical predictors of stroke afterTIA. Nineteen relevant studies were identified using electronic and hand searches. Determinants of DWI positivity following TIA were studied. Longer symptom duration, motor weakness, dysphasia and dysarthria were associated with the presence of lesions on DWI, whereas sex, hypertension and diabetes were not.
47. Flossmann E, Rothwell PM. Prognosis of vertebrobasilar transient ischaemic attack and minor stroke. Brain 2003; 126 (Pt 9):1940-1954.
48. Antithrombotic trialists collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324:71-86.
49. Kennedy J, Hill MD, Ryckborst KJ, et al., for the FASTER Investigators. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 2007; 6:961-969. Randomized controlled trial of clopidogrel and aspirin versus aspirin alone and simvastatin versus placebo for stroke prevention in 392 patients in the acute phase after TIA. The primary outcome was stroke at 90 days. Fourteen (7.1 %) patients on clopidogrel had a stroke within 90 days compared with 21 (10.8%) patients on placebo [risk ratio 0.7 (95% Cl 0.3-1.2)]. Twenty-one (10.6%) patients on simvastatin had a stroke within 90 days compared with 14 (7.3%) patients on placebo [risk ratio 1.3 (0.7-2.4)].
50. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348:1329-1339.
51. Halkes PH, van Gijn J, Kappelle LJ, et al., ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367:1665-1673.
52. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-1041.
53. Amarenco P, Bogousslavsky J, Callahan A III, et al., for the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355:549-559.
54. European Atrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342:1255-1262.
55. Rothwell PM, Gutnikov SA, Eliasziw M, et al., for the Carotid Endarterectomy Trialists' Collaboration. Pooled analysis of individual patient data from randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361:107-116.
56. Rothwell PM, Eliasziw M, Gutnikov SA, et al., for the Carotid Endarterectomy Trialists Collaboration. Effect of endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and to the timing of surgery. Lancet 2004; 363:915-924.
57. Hackam DG, Spence JD. Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke 2007; 38:1881-1885.
58. Rothwell PM, Giles MF, Chandratheva A, et al., on behalf of the Early use of Existing Preventive Strategies for Stroke (EXPRESS) Study. Major reduction in risk of early recurrent stroke by urgent treatment of TIA and minor stroke: EXPRESS Study. Lancet 2007; 370:1432-1442. Prospective population-based sequential comparison of urgent assessment and secondary prevention treatment for TIA.
59. Lavallée PC, Meseguer E, Abboud H, et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 2007; 6:953-960. Observational study of impact of urgent assessment and treatment in specialist clinic in TIA.